Delivery Order SPE2DB22D3301-SPE2DB25FX5GR
Award Date
11/12/24
Potential Completion Date
11/13/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $61,695.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4564977738 ACTIVASE 100 MG VIALS, a critical medical product, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award, valued at $23,241.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ACTIVASE 100 MG VIALS, with a period of performance through March 1, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,745.66 firm fixed-price delivery order contract, with a completion date of January 22, 2024, is for 4,563,371,774 units of ACTIVASE 100 MG VIALS. This contract is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,290.62, is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which runs through November 2026. The contract is for the supply of ACTIVASE 50 MG VIALS, a critical medical commodity. This contract...
This federal contract award, valued at $19,759.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of ACTIVASE 100 MG VIALS, a critical medical product. The contract has a ceiling value of $19,759.06 and a period of performance through November 22, 2024. This award is not designated as a set-aside contract. The contract is part of a larger...
This federal contract award, valued at $19,953.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560956486 ACTIVASE 100 MG VIALS, a medical product used in healthcare. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 17, 2023. This award is not associated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,679.70 firm-fixed-price delivery order is for the supply of 50mg vials of the drug ACTIVASE, with a completion date of February 7, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,266.89 firm fixed price delivery order is for the supply of 4,568,373,042 units of ACTIVASE 50 MG VIALS. The contract has an ultimate completion date of May 29, 2025 and is not set aside. AmerisourceBergen Drug Corp is a for-profit company that serves as a critical supplier of medical and pharmaceutical products...
This federal contract award, valued at $12,678.28, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of ACTIVASE 100 MG VIALS medical products, with a period of performance through October 31, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
This federal contract award, valued at $14,108.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...